These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9853025)

  • 1. [Focalized matrix proteolysis and inflammation].
    Gaudin P; Trocmé C; Monier F; Zaoui P; Barro C; Polack B; Hadjian A; Berthier S; Morel F
    Ann Biol Clin (Paris); 1998; 56(6):661-9. PubMed ID: 9853025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation mechanisms of matrix metalloproteinases.
    Nagase H
    Biol Chem; 1997; 378(3-4):151-60. PubMed ID: 9165065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of matrix metalloproteinases and TIMPs.
    Nagase H; Visse R; Murphy G
    Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases. A mini-review.
    Nagase H
    Contrib Nephrol; 1994; 107():85-93. PubMed ID: 8004978
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent progress of matrix metalloproteinase (MMP) research and its clinical application for cancer therapy].
    Otani Y; Fujii M; Kubota T; Kitajima M; Okada Y
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):957-64. PubMed ID: 9644306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The matrix metalloproteinases and their inhibitors.
    Murphy G; Docherty AJ
    Am J Respir Cell Mol Biol; 1992 Aug; 7(2):120-5. PubMed ID: 1497900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMPs as multifacial proteins.
    Lambert E; Dassé E; Haye B; Petitfrère E
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of matrix metalloproteinases in the oral environment.
    Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
    Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix remodelling: the role of matrix metalloproteinases.
    Stamenkovic I
    J Pathol; 2003 Jul; 200(4):448-64. PubMed ID: 12845612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metalloproteinases in the extracellular matrix: structure and activity].
    Cuvelier A; Kuntz C; Sesboüé R; Muir JF; Martin JP
    Rev Mal Respir; 1997 Jan; 14(1):1-10. PubMed ID: 9082500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors.
    Maskos K
    Biochimie; 2005; 87(3-4):249-63. PubMed ID: 15781312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural features of the reprolysin atrolysin C and tissue inhibitors of metalloproteinases (TIMPs) interaction.
    Pinto AF; Terra RM; Guimarães JA; Kashiwagi M; Nagase H; Serrano SM; Fox JW
    Biochem Biophys Res Commun; 2006 Sep; 347(3):641-8. PubMed ID: 16842758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Implication of extracellular matrix metalloproteinases in the course of chronic inflammatory airway diseases].
    Lechapt-Zalcman E; Escudier E
    Morphologie; 2000 Jun; 84(265):45-9. PubMed ID: 11048298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
    Hamacher S; Matern S; Roeb E
    Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activation mechanisms, biological role and inhibitors of metalloproteases in the extracellular matrix].
    Gacko M
    Postepy Hig Med Dosw; 2001; 55(2):303-18. PubMed ID: 11468976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S; Lijnen HR
    Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Matrix metalloproteases (MMPS)].
    Gacko M
    Postepy Hig Med Dosw; 1997; 51(5):577-89. PubMed ID: 9489456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.